IVF Add-Ons: What They Are, What They Cost, and Whether They Work

An IVF add-on is an optional extra sold alongside a standard cycle, and for most patients most add-ons do not have good evidence that they improve the chance of a live birth. That sentence took me two rounds and a lot of money to arrive at. Here is what the common extras are, how to weigh one when it is offered to you, and why saying no is a reasonable answer.

What counts as an add-on

A standard IVF cycle is a complete treatment on its own: stimulation, egg collection, fertilisation in the lab, embryo development, transfer, and the wait. If you want that sequence in detail, IVF explained walks through it. An add-on is anything sold on top of that: a laboratory technique, an extra test, a drug, or a procedure, usually charged separately¹.

That last part matters more than it sounds. Because add-ons sit outside the headline price, two clinics quoting similar figures can end up costing very different amounts once the extras are counted, which is exactly why the regulator advises asking for an itemised costed treatment plan before you commit². Our guide to what IVF costs goes through the rest of the bill.

The extras you are most likely to be offered

These are the names that came up in our consultations, in roughly the order clinics tend to raise them.

• Time-lapse imaging. A camera inside the incubator photographs embryos continuously, so the lab can watch development without taking them out. Useful for the embryologists; the question is whether it changes which embryo gets chosen, and whether that changes the outcome.
• Endometrial scratch. A deliberate small injury to the womb lining in the cycle before treatment, on the theory that the healing response helps an embryo implant. Widely offered for years on early promise that later trials did not bear out for most patients.
• Assisted hatching. Thinning or opening the embryo’s outer shell in the lab to help it break out and implant.
• Embryo glue. A transfer medium containing hyaluronate, intended to help the embryo stick.
• Genetic testing of embryos (PGT-A). Biopsying embryos to check the chromosome count so those testing normal are transferred first.
• Immune tests and treatments. Blood tests for immune activity, sometimes followed by drugs such as steroids or intralipids, usually offered after repeated failed transfers or recurrent miscarriage.
• Artificial egg activation and other lab techniques offered for specific fertilisation problems, usually alongside ICSI.

How to judge one when it is offered

The direct answer is that most of these do not have strong evidence of improving live birth rates for most patients, and some have essentially none¹. A few may help particular groups in particular circumstances. The trick is telling those apart in a room where you are frightened and someone kind is describing something that sounds like it can only help.

Three questions do most of the work.

What outcome does it improve? Not “does it help”, but help what. An add-on can genuinely improve a laboratory measure, how embryos are selected, or a pregnancy rate, and still not change how many babies are born. Live birth is the number that counts, for the same reasons set out in what the success statistics really mean.

In whom? An extra that helps people with a specific diagnosis is not an extra that helps everyone, and “we offer it to all our patients” is a business model rather than an indication. Ask what about your history makes them suggest it for you.

What does the evidence look like? Ask whether it comes from large randomised trials or from a clinic’s own observed results, and ask what the regulator’s current rating is. The HFEA reviews the published evidence for each add-on and publishes a colour-coded rating alongside a plain explanation, and those ratings change as new trials report, so check the current page rather than a leaflet¹. National guidance takes a similarly careful line: NICE’s fertility guideline recommends a fairly lean set of core interventions and does not endorse a long tail of extras³, and professional bodies describe the standard cycle itself as the established treatment⁴.

The pressure you will feel, and what helped me

Nobody sold me an add-on aggressively. That is not how it happens. What happens is that you are in round two, you have watched one cycle fail, and someone offers you a thing that might improve your odds for a few hundred pounds more, and the maths in your head is not really about evidence. It is about how you will feel in six weeks if it does not work and you did not take the option.

We paid for one extra on our second round. I still do not know whether it did anything, and I have made my peace with that. What I would do differently is decide about extras at the quote stage, in a calm week, with the list written down, rather than in the consulting room on the day. Deciding in advance protected me from the version of myself who would have agreed to anything.

It is also worth naming that declining is normal. Consent to an add-on is separate from consent to your cycle, and a good clinic explains its reasoning, accepts your answer, and treats you the same either way. If saying no changes the temperature of your care, that tells you something about the clinic rather than about your chances.

Where the money is better spent

If the budget is finite, and for almost everyone it is, the honest comparison is not “add-on versus nothing”. It is “add-on versus another cycle”. Because each individual cycle has a limited chance and the cumulative picture across cycles is usually the more realistic one, a few hundred pounds of extras on one attempt can be worth less than the same money kept towards the next attempt. That was the calculation that finally settled it for us, and it was a spreadsheet conversation rather than a medical one.

The exceptions run the other way too: a test that would genuinely change your treatment plan, or a technique your clinic can explain a specific reason for in your case, may be well worth having. That is why the three questions matter more than any list of names.

This is general information, not advice about your treatment, and the evidence behind individual add-ons changes. Ask your own fertility team what they are recommending for you and why, and check the regulator’s current rating before you decide.